Strategic Initiative

Slingshot members are tracking this corporate initiative:

Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer

Source Link:
http://press.pfizer.com/press-release/merck-kgaa-darmstadt-germany-pfizer-and-verastem-announce-combination-trial-avelumab-a

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MRK Community voting in process
PFE Community voting in process
VSTM Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Mar 03, 2016
Projected Implementation:
Q1, 2016
Relevance Tracked Until:
Q2, 2016
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Trial Of Avelumab, Vs-6063, Phase I/ib Clinical Trial Phase I/ib Clinical, Ovarian Cancer
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.